If our findings are successfully replicated in other well-powered studies, certain variants of the LEP and LEPR genes may serve as novel prognostic biomarkers for CRC, and CRC survivors may improve their prognosis through lifestyle changes. The gene discussed is LEPR; the disease is colorectal carcinoma.